Moderna's Covid-19 vaccine may come to India through govt route
After US-based Moderna, Inc. released the interim data from late-stage trials that showed its vaccine candidate was 94.5 per cent efficacious against the Sars-CoV-2 virus, the ball has been set rolling in India. Read more...
Goldman ups India GDP forecast on vaccine hopes, now sees 10.8% contraction
Foreign brokerage Goldman Sachs on Tuesday upgraded its India GDP forecast to a contraction of 10.3 per cent in FY21, as against its earlier estimate of a negative growth of 14.8 per cent. Read more...
Lakshmi Vilas Bank under moratorium; RBI proposes